CIMT 2018 Annual Meeting

May 15-17, 2018

Rheingoldhalle Congress Center Mainz, Germany

Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT 2018 invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.

For 2018, the CIMT program committee is preparing plenary sessions from pre-clinical research to clinical development on the topics of therapeutic vaccination, cellular therapy, improving immunity, tumor microenvironment, antibodies, regulatory research and immunoguiding. The plenary sessions will be complemented by a poster exhibit and selected poster short talk sessions, as well as industry symposia and industry exhibits.

CIMT selects young scientists from underrepresented countries for travel awards of up to 1000 EUR plus free conference admission to offset meeting-related expenses.
Travel awards can only be issued to scientists who have submitted an abstract and are registered to attend the meeting. Please go to http://www.meeting.cimt.eu/call_for_abstracts for more information.

 

 

2018 Scientific Planning Committee

Mustafa Diken
TRON-Translational Oncology, Mainz/Germany; CIMT Scientific Secretary

Michael Kalos
Eli Lilly, New York, NY/USA

Sine Reker Hadrup
Denmark Technical University, Copenhagen/Denmark

Marij Welters
Leiden University Medical Center, Leiden/The Netherlands

Christian Buchholz
Paul-Ehrlich-Institute (PEI), Langen/Germany

Sebastian Kreiter
TRON-Translational Oncology, Mainz/Germany; Head CIMT Management Board